Chris Freeman - Jun 9, 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Commercial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Chris Freeman
Stock symbol
GH
Transactions as of
Jun 9, 2023
Transactions value $
$0
Form type
4
Date filed
6/13/2023, 05:40 PM
Previous filing
Nov 9, 2022
Next filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +25.1K $0.00 25.1K Jun 9, 2023 COMMON STOCK 25.1K $32.86 Direct F1
transaction GH RESTRICTED STOCK UNITS Award $0 +16.7K $0.00 16.7K Jun 9, 2023 COMMON STOCK 16.7K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 9, 2024, and the remaining 67% of the shares vests in equal installments on each monthly anniversary of June 9, 2024, during the two-year period thereafter.
F2 This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F3 Not applicable for Restricted Stock Units.